Ifp Advisors, Inc Athenex, Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$0.17 - $3.42 $850 - $17,100	-5,000 Reduced 99.3%	35 $0
Q4 2022 Feb 07, 2023	BUY	$0.12 - $0.21 $600 - $1,050	5,000 Added 14285.71%	5,035 $82,000
Q2 2022 Sep 06, 2022	BUY	$0.41 - $0.91 $14 - $31	35 New	35 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $14 - $31	-35 Closed	0 $0
Q4 2021 Jan 12, 2022	BUY	$1.36 - $2.94 $47 - $102	35 New	35 $1,000
Q3 2021 Oct 06, 2021	SELL	$2.97 - $4.84 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$3.71 - $5.13 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$4.08 - $14.75 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$11.06 - $14.01 $121 - $154	-11 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$10.26 - $14.55 $112 - $160	11 New	11 $0

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.